Efficacy and safety of human umbilical cord derived mesenchymal stem cell therapy in children with severe aplastic anemia following allogeneic hematopoietic stem cell transplantation: A retrospective case series of 37 patients
机构:[a]Department of Children's Hematology and Oncology, Bayi Children's Hospital Affiliated to General Hospital of Beijing Military Command, Beijing 100700, China[b]Department of Hematology, Beijing Military General Hospital, Beijing, China
This study was supported by China Postdoctoral Science Foundation (Grant No.20110491906).
语种:
外文
中科院(CAS)分区:
出版当年[2013]版:
大类|4 区医学
小类|4 区血液学4 区肿瘤学4 区儿科
最新[2023]版:
大类|4 区医学
小类|4 区血液学4 区肿瘤学4 区儿科
第一作者:
推荐引用方式(GB/T 7714):
Si Y,Yang K,Qin M,et al.Efficacy and safety of human umbilical cord derived mesenchymal stem cell therapy in children with severe aplastic anemia following allogeneic hematopoietic stem cell transplantation: A retrospective case series of 37 patients[J].PEDIATRIC HEMATOLOGY AND ONCOLOGY.2014,31(1):doi:10.3109/08880018.2013.867556.
APA:
Si, Y,Yang, K,Qin, M,Zhang, C,Du, Z...&Feng, Z.(2014).Efficacy and safety of human umbilical cord derived mesenchymal stem cell therapy in children with severe aplastic anemia following allogeneic hematopoietic stem cell transplantation: A retrospective case series of 37 patients.PEDIATRIC HEMATOLOGY AND ONCOLOGY,31,(1)
MLA:
Si, Y,et al."Efficacy and safety of human umbilical cord derived mesenchymal stem cell therapy in children with severe aplastic anemia following allogeneic hematopoietic stem cell transplantation: A retrospective case series of 37 patients".PEDIATRIC HEMATOLOGY AND ONCOLOGY 31..1(2014)